JT Stratford LLC’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-24,706
| Closed | -$1.33M | – | 302 |
|
|
2025
Q4 | $1.33M | Buy |
+24,706
| New | +$1.19M | 0.17% | 127 |
|
|
2025
Q2 | – | Sell |
-29,702
| Closed | -$1.81M | – | 304 |
|
|
2025
Q1 | $1.81M | Sell |
29,702
-3,852
| -11% | -$225K | 0.32% | 76 |
|
|
2024
Q4 | $1.9M | Buy |
33,554
+22,929
| +216% | +$1.28M | 0.31% | 76 |
|
|
2024
Q3 | $550K | Sell |
10,625
-236
| -2% | -$11.1K | 0.09% | 199 |
|
|
2024
Q2 | $451K | Buy |
+10,861
| New | +$486K | 0.08% | 202 |
|
|
2023
Q3 | – | Sell |
-4,932
| Closed | -$315K | – | 231 |
|
|
2023
Q2 | $315K | Buy |
4,932
+64
| +1% | +$4.29K | 0.08% | 194 |
|
|
2023
Q1 | $337K | Buy |
4,868
+1,174
| +32% | +$82.8K | 0.1% | 189 |
|
|
2022
Q4 | $266K | Buy |
3,694
+78
| +2% | +$5.88K | 0.09% | 189 |
|
|
2022
Q3 | $257K | Buy |
3,616
+259
| +8% | +$18.8K | 0.09% | 170 |
|
|
2022
Q2 | $258K | Buy |
3,357
+10
| +0.3% | +$762 | 0.08% | 184 |
|
|
2022
Q1 | $244K | Sell |
3,347
-59
| -2% | -$3.96K | 0.07% | 184 |
|
|
2021
Q4 | $212K | Sell |
3,406
-60
| -2% | -$3.52K | 0.06% | 196 |
|
|
2021
Q3 | $205K | Buy |
3,466
+74
| +2% | +$4.87K | 0.06% | 205 |
|
|
2021
Q2 | $227K | Sell |
3,392
-850
| -20% | -$55.4K | 0.07% | 192 |
|
|
2021
Q1 | $268K | Sell |
4,242
-16,711
| -80% | -$1.04M | 0.09% | 164 |
|
|
2020
Q4 | $1.3M | Buy |
20,953
+626
| +3% | +$38.5K | 0.49% | 53 |
|
|
2020
Q3 | $1.23M | Sell |
20,327
-282
| -1% | -$17K | 0.53% | 51 |
|
|
2020
Q2 | $1.21M | Buy |
20,609
+436
| +2% | +$26.1K | 0.62% | 55 |
|
|
2020
Q1 | $1.12M | Sell |
20,173
-5,899
| -23% | -$361K | 0.69% | 48 |
|
|
2019
Q4 | $1.67M | Sell |
26,072
-14,107
| -35% | -$808K | 0.77% | 42 |
|
|
2019
Q3 | $2.04M | Sell |
40,179
-3,875
| -9% | -$182K | 1.15% | 30 |
|
|
2019
Q2 | $2M | Buy |
44,054
+1,772
| +4% | +$82.5K | 1.11% | 22 |
|
|
2019
Q1 | $2.02M | Sell |
42,282
-4,051
| -9% | -$202K | 1.16% | 22 |
|
|
2018
Q4 | $2.41M | Sell |
46,333
-3,552
| -7% | -$191K | 1.6% | 17 |
|
|
2018
Q3 | $3.1M | Buy |
49,885
+63
| +0.1% | +$3.74K | 1.78% | 13 |
|
|
2018
Q2 | $2.76M | Buy |
49,822
+1,813
| +4% | +$97.9K | 1.7% | 17 |
|
|
2018
Q1 | $3.04M | Sell |
48,009
-69
| -0.1% | -$4.44K | 1.9% | 14 |
|
|
2017
Q4 | $2.95M | Buy |
48,078
+405
| +0.8% | +$25.3K | 1.92% | 11 |
|
|
2017
Q3 | $3.04M | Buy |
47,673
+17,338
| +57% | +$1.01M | 1.97% | 9 |
|
|
2017
Q2 | $1.69M | Buy |
30,335
+18,437
| +155% | +$1M | 1.19% | 31 |
|
|
2017
Q1 | $647K | Sell |
11,898
-15,929
| -57% | -$874K | 0.48% | 56 |
|
|
2016
Q4 | $1.63M | Buy |
+27,827
| New | +$1.52M | 1.37% | 29 |
|
Other funds holding BMY
JT Stratford LLC's BMY Position: Q1 2026 in Review
JT Stratford LLC sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 24,706 shares — an estimated $1.33M sold.
JT Stratford LLC first reported a position in BMY in Q4 2016 and held it in 32 quarters. The position peaked at $3.1M in Q3 2018. 2,532 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- JT Stratford LLC reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
- JT Stratford LLC sold 24,706 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.33M.
- JT Stratford LLC first reported a position in Bristol-Myers Squibb in Q4 2016 and held it in 32 quarters.
- JT Stratford LLC's Bristol-Myers Squibb position peaked at $3.1M in Q3 2018.
- 2,532 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on JT Stratford LLC's 13F filing for Q1 2026, filed 15 May 2026.